Mercer Global Advisors
CGTX icon

Mercer Global Advisors’s Cognition Therapeutics CGTX Stock Holding History

Mercer Global Advisors’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1K Hold
15,951
– – ﹤0.01% 3202
2025
Q4 		$21.5K Hold
15,951
– – ﹤0.01% 2820
2025
Q3 		$21.5K Sell
15,951
-100
-0.6% -$136 ﹤0.01% 2616
2025
Q2 		$4.97K Hold
16,051
– – ﹤0.01% 2246
2025
Q1 		$6.75K Hold
16,051
– – ﹤0.01% 2141
2024
Q4 		$11.3K Hold
16,051
– – ﹤0.01% 2110
2024
Q3 		$7.07K Sell
16,051
-79,900
-83% -$82.4K ﹤0.01% 1948
2024
Q2 		$159K Buy
95,951
+24,050
+33% +$47.9K ﹤0.01% 1827
2024
Q1 		$131K Sell
71,901
-59,050
-45% -$122K ﹤0.01% 1836
2023
Q4 		$242K Buy
130,951
+115,000
+721% +$152K ﹤0.01% 1741
2023
Q3 		$23K Hold
15,951
– – ﹤0.01% 1922
2023
Q2 		$29K Buy
+15,951
New +$33.8K ﹤0.01% 1883

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Mercer Global Advisors's CGTX Position: Q1 2026 in Review

Mercer Global Advisors held its Cognition Therapeutics (CGTX) position steady in Q1 2026 at 15,951 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3202.

Mercer Global Advisors first reported a position in CGTX in Q2 2023 and has held it in 12 quarters since. The position peaked at $242K in Q4 2023. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Mercer Global Advisors held 15,951 shares of Cognition Therapeutics worth $12.1K as of Q1 2026.
  • Mercer Global Advisors left its Cognition Therapeutics share count unchanged in Q1 2026.
  • Cognition Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3202 holding.
  • Mercer Global Advisors first reported a position in Cognition Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Mercer Global Advisors's Cognition Therapeutics position peaked at $242K in Q4 2023.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.